Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy?

TheMotleyFool

0 0

Iovance Therapeutics Stock Has Skyrocketed Over 100% so Far This Year. Is It Still a Buy?: https://g.foolcdn.com/editorial/images/766990/scientists-in-a-lab-smiling.jpg

Some investors are attracted to small biotech stocks because of their potential for explosive returns. It's not uncommon for these stocks to go parabolic after positive news is announced.

That's exactly what happened to Iovance Biotherapeutics (NASDAQ: IOVA). The stock has skyrocketed more than 100% so far in 2024. But is Iovance Biotherapeutics still a buy after this huge gain?

As of Feb. 16, 2024, Iovance's share price was up only around 13% year to date. When the market opened on the next business day following the Presidents' Day holiday, the stock took off and hasn't stopped climbing since.

Source Fool.com

Like: 0

IOVA

Share